Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ABO-incompatible heart transplantation in infants.

L J West1, S M Pollock-Barziv, A I Dipchand

  • 1Department of Paediatrics, Hospital for Sick Children and University of Toronto, ON, Canada. lwest@sickkids.on.ca

The New England Journal of Medicine
|March 15, 2001
PubMed
Summary

ABO-incompatible heart transplants in infants are safe and effective, significantly reducing waiting list mortality. This approach avoids hyperacute rejection in newborns before antibody development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II.

Frontiers in immunology·2023
Same author

Incidence, characterization, and impact of newly detected donor-specific anti-HLA antibody in the first year after pediatric heart transplantation: A report from the CTOTC-04 study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2018
Same author

Patterns of kidney injury in pediatric nonkidney solid organ transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Right ventricular function during exercise in children after heart transplantation.

European heart journal. Cardiovascular Imaging·2017
Same author

Risk factors for specific causes of death following pediatric heart transplant: An analysis of the registry of the International Society of Heart and Lung Transplantation.

Pediatric transplantation·2015
Same author

Development and Impact of De Novo Anti-HLA Antibodies in Pediatric Heart Transplant Recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015

Area of Science:

  • Pediatric Cardiology
  • Transplant Immunology
  • Organ Transplantation

Background:

  • ABO-incompatible donor hearts traditionally risk hyperacute rejection due to preformed antibodies.
  • Newborn infants may not produce antibodies to major blood group antigens, potentially altering this risk.

Purpose of the Study:

  • To evaluate the safety and efficacy of ABO-incompatible heart transplantation in infants.
  • To assess the impact of this strategy on reducing infant heart transplant waiting list mortality.

Main Methods:

  • Studied 10 infants (4 months–14 months) receiving ABO-incompatible heart transplants.
  • Monitored isohemagglutinin titers, performed plasma exchange, and used standard immunosuppression.
  • Compared outcomes with 10 infants receiving ABO-compatible transplants.

Related Experiment Videos

Main Results:

  • 80% survival rate in ABO-incompatible recipients; no hyperacute rejection observed.
  • Mild humoral rejection in one case; no graft damage despite antibody development.
  • Waiting list mortality decreased from 58% to 7% due to ABO-incompatible transplants.

Conclusions:

  • ABO-incompatible heart transplantation is safe in infants before isohemagglutinin production.
  • This method significantly reduces mortality for infants awaiting heart transplants.